Chemomab Therapeutics Reports Mid-Year Financials
PremiumCompany AnnouncementsChemomab Therapeutics Reports Mid-Year Financials
3M ago
Chemomab Therapeutics sees cash runway through beginning of 2026
Premium
The Fly
Chemomab Therapeutics sees cash runway through beginning of 2026
3M ago
Chemomab Therapeutics reports Q2 EPS (1c) vs. (4c) last year
Premium
The Fly
Chemomab Therapeutics reports Q2 EPS (1c) vs. (4c) last year
3M ago
Chemomab’s CM-101 Shows Promise in PSC Trial
PremiumCompany AnnouncementsChemomab’s CM-101 Shows Promise in PSC Trial
4M ago
Chemomab Therapeutics announces $10M private placement
Premium
The Fly
Chemomab Therapeutics announces $10M private placement
4M ago
Chemomab Therapeutics announces Phase 2 trial results for CM-101
Premium
The Fly
Chemomab Therapeutics announces Phase 2 trial results for CM-101
4M ago
Chemomab Therapeutics initiated with a Buy at Maxim
PremiumThe FlyChemomab Therapeutics initiated with a Buy at Maxim
6M ago
Chemomab Therapeutics initiated with a Buy at Maxim
Premium
The Fly
Chemomab Therapeutics initiated with a Buy at Maxim
6M ago
Chemomab Advances PSC Trial with Promising Outlook
Premium
Company Announcements
Chemomab Advances PSC Trial with Promising Outlook
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100